Log In
Print
BCIQ
Print
Print this Print this
 

Opana ER (Oxymorphone ER)

Also known as: EN3202

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionExtended-release opioid analgesic formulated using TIMERx delivery technology
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat moderate to severe cancer pain; Treat moderate to severe chronic low back pain; Treat moderate to severe pain; Treat moderate to severe pain in patients who require continuous opioid therapy; Treat pain; Treat post-operative pain; Treat severe osteoarthritis (OA) pain
Regulatory Designation

U.S. - Priority Review (Treat moderate to severe pain in patients who require continuous opioid therapy)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today